Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Available

Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition

REGENECYTE® (HPC, Cord Blood (Hematopoietic Progenitor Cell, Cord Blood)) for treatment in patients with post-COVID.

Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: StemCyte, Inc.Updated: Mar 23, 2026Locations: 2
Eligibility criteria

Male or female aged ≥ 18 [+5]

Neurological disorders prior to COVID-19 diagnosis [+7]

Read more
Status: Not yet recruiting

Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)

A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke

Participants needed: 39
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: StemCyte, Inc.Updated: Feb 27, 2025
Eligibility criteria

Male or female subject ≥18 and ≤80 years of age. [+1]

Subject with known immune disease, immunodeficiency, or receives immunosuppressi...

Read more